Aakaar Medical Technologies Ltd. (NSE:AAKAAR)
60.00
0.00 (0.00%)
At close: Jan 20, 2026
NSE:AAKAAR Revenue
Aakaar Medical Technologies had revenue of 126.63M INR in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 592.04M. In the fiscal year ending March 31, 2025, Aakaar Medical Technologies had annual revenue of 615.83M with 33.55% growth.
Revenue (ttm)
592.04M
Revenue Growth
+33.55%
P/S Ratio
1.48
Revenue / Employee
3.34M
Employees
177
Market Cap
878.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 615.83M | 154.72M | 33.55% |
| Mar 31, 2024 | 461.11M | 133.26M | 40.65% |
| Mar 31, 2023 | 327.85M | 133.19M | 68.43% |
| Mar 31, 2022 | 194.65M | 70.27M | 56.50% |
| Mar 31, 2021 | 124.38M | -105.44M | -45.88% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emami | 37.15B |
| Bajaj Consumer Care | 10.89B |
| Anondita Medicare | 996.83M |
| MFL India | 576.82M |
| Ravelcare | 249.79M |
| Paramount Cosmetics (India) | 249.03M |
| Novateor Research Laboratories | 44.54M |
| Raghunath International | 13.64M |